The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types of ...

The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types ...

Tolmar, Inc. (Tolmar) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Rubraca® (rucaparib), enabling its use prior to chemotherapy for eligible ...

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, including heart disease and fatty liver disease (MASLD).

Candidates can download GATE Life Sciences previous year question papers with solutions in PDF. Practice the GATE Life ...

PDF files have become ubiquitous in our multi-platform world. This convenient file format makes it possible to view and share documents across various devices using various operating systems and ...

Pseudohypertrophy of muscles is a rare and under-recognised form of hypothyroid myopathy primarily affecting the calf muscles, in association with elevated muscle enzymes. We report the case of an ...

The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD). Three proteases that are involved in the processing of ...

With the continued popularity of dietary supplements, we’ve curated credible sources of information, fact-checked data and ...

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...